CS logo
small CS logo
The Cognitive and Research Center of New Jersey

Springfield, New Jersey, United States
Research institute in Springfield Township, New Jersey
195 Mountain Ave, Springfield, NJ 07081

About The Cognitive and Research Center of New Jersey


"At The CRCNJ, we understand that treating cognitive disorders means more than just managing symptoms. That’s why we take a multidisciplinary approach to treatment, with specialists in neuropsychology, psychotherapy, group therapy, clinical trials, and specialized collaborative consultants in neurology and psychiatry."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at The Cognitive and Research Center of New Jersey


During the past decade, The Cognitive and Research Center of New Jersey conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 12 clinical trials were completed, i.e. on average, 48% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)
2011-12-01
2018-12-14
Completed
51
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
2016-09-01
2023-08-01
Active, not recruiting
539
A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
2020-10-12
2025-06-30
Recruiting
31
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)
2021-05-26
2025-06-01
Active, not recruiting
212
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
2021-05-27
2026-05-23
Recruiting
440
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
2021-02-25
2025-08-23
Recruiting
309
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
2022-06-23
2033-01-26
Recruiting
864

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "The Cognitive and Research Center of New Jersey" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Cognito Therapeutics, Inc." with 2 trials sponsored and "Avid Radiopharmaceuticals" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Cognitive and Research Center of New Jersey" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at The Cognitive and Research Center of New Jersey


According to Clinical.Site data, the most researched conditions in "The Cognitive and Research Center of New Jersey" are "Alzheimer Disease" (13 trials), "Alzheimer's Disease" (8 trials), "Mild Cognitive Impairment" (4 trials), "Cognitive Decline" (2 trials) and "Cognitive Impairment" (2 trials). Many other conditions were trialed in "The Cognitive and Research Center of New Jersey" in a lesser frequency.

Clinical Trials Intervention Types at The Cognitive and Research Center of New Jersey


Most popular intervention types in "The Cognitive and Research Center of New Jersey" are "Drug" (26 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "Donanemab" (3 trials), "Gantenerumab" (3 trials), "Crenezumab" (2 trials) and "Lanabecestat" (2 trials). Other intervention names were less common.

Clinical Trials Genders at The Cognitive and Research Center of New Jersey


The vast majority of trials in "The Cognitive and Research Center of New Jersey" are 28 trials for "All" genders.

Clinical Trials Status at The Cognitive and Research Center of New Jersey


Currently, there are NaN active trials in "The Cognitive and Research Center of New Jersey". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in The Cognitive and Research Center of New Jersey, 1 suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in The Cognitive and Research Center of New Jersey, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status